Key facts
- Rozmova’s last known valuation is $12.0M (Jul 2025).
- It has raised $1.3M; the latest was Seed Round ($910K) in Jul 2025.
- Notable investors include Seeds of Bravery, Purple Ventures (Brno), Angel One (Ukraine), Dmytro Orel, Google Accelerator — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Rozmova
- ·The full record, as it builds
Funding rounds
No funding rounds for Rozmova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rozmova
Developer of a healthcare platform designed to connect clients with certified psychotherapists and counselors. The company allows finding the right therapist and verifies therapists' qualifications, education, and experience, enabling patients to improve their mental health and make psychotherapy more accessible.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2021
- Employees
- 31
- Website
- rozmova.me/
- Ownership
- Privately Held (backing)
Rozmova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rozmova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rozmova in its N-PORT filings yet. We sweep new filings monthly.